Rosen Law Firm & MiNK Therapeutics

Rosen Law Firm: Rosen Law Firm is the plaintiff's counsel leading the class action against MiNK Therapeutics. The firm stands to gain contingency fees if the case succeeds, and the case enhances its reputation in securities litigation.

MiNK Therapeutics: MiNK Therapeutics is the defendant in the securities class action, facing allegations of misleading investors about the safety and prospects of its drug candidate ARD-101. The lawsuit could result in financial damages, increased legal costs, and reputational harm, negatively affecting its stock and operations.